Melanoma and vitamin D
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Vitamin D is a fat‐soluble steroid hormone, which is essential to health and for which epidemiological studies suggest a role in autoimmune disease, infections, cardiovascular disease and cancer. It is ingested in foods such as oily fish and supplements, so that average levels vary between countries, but most individuals worldwide make most of their vitamin D as a result of the effects of sun exposure on the skin. Many studies in different populations around the world have in recent years shown that sub‐optimal levels of vitamin D (<70 nmol/L) are common. A series of epidemiological studies have suggested that low vitamin D levels increase the risk of cancers, particularly of the breast and gastrointestinal tracts, so that there has been much interest in understanding the effects of vitamin D on cancer cells. Vitamin D binds to the vitamin D receptor (VDR) resulting in transcription of a number of genes playing a role in inhibition of MAPK signalling, induction of apoptosis and cell‐cycle inhibition, and therefore vitamin D has anti‐proliferative and pro‐apoptotic effects in cells of many lineages. It also has suppressive effects on adaptive immunity and is reported to promote innate immunity. Here we review data on vitamin D and melanoma. There are in vitro data, which suggest that vitamin D has the same anti‐proliferative effects on melanoma cells as have been demonstrated in other cells. We have reported data to suggest that vitamin D levels at diagnosis have a role in determining outcome for melanoma patients. There is a curious relationship between melanoma risk and sun exposure where sunburn is causal but occupational sun exposure is not (at least in temperate climes). Seeking to understand this, we discuss data, which suggest (but by no means prove) that vitamin D might also have a role in susceptibility to melanoma. In conclusion, much remains unknown about vitamin D in general and certainly about vitamin D and melanoma. However, the effects of avoidance of suboptimal vitamin D levels on cancer cell proliferation are likely to be beneficial to the melanoma patient. The possible results of high vitamin D levels on the immune system remain unclear however and a source of some concern, but the data support the view that serum levels in the range 70–100 nmol/L might be a reasonable target for melanoma patients as much as for other members of the population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1678s · Cited by 3,198
Vitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.016 · Cited by 1,266 · cited 2×
“Although epidemiological studies have established a clear relationship between sun exposure andmelanoma risk (Gandini et al., 2005), the nature of this relationship has proved com-”
BackgroundResultAutier, P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1730 · Cited by 1,104
Nesby-O’Dell, S., Scanlon, K. S., Cogswell, M. E., Gillespie, C., Hollis, B. W., Looker, A. C., Allen, C., Doughertly, C., Gunter, E. W., & Bowman, B. A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.187 · Cited by 1,001
Hyppönen, E., & Power, C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.860 · Cited by 756 · cited 1×
“Higher levels with vitamin supplements or oily fish intake (Hypponen and Power, 2007)”
BackgroundVitamin D status in relation to one-year risk of recurrent falling in older men and women
Snijder, M. B., van Schoor, N. M., Pluijm, S. M. F., van Dam, R. M., Visser, M., & Lips, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0510 · Cited by 311
Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y.-M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1135 · Cited by 295
Self-citationVitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice
Froicu, M., Zhu, Y., & Cantorna, M. T. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02290.x · Cited by 128
Polymorphisms in the MTHFR and VDR genes and skin cancer risk
Han, J., Colditz, G. A., & Hunter, D. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl156 · Cited by 110
Cited by
Modulation of the immune system by UV radiation: More than just the effects of vitamin D?
Hart, P. H., Gorman, S., & Finlay-Jones, J. J. (2011) · Nature Reviews Immunology · doi:10.1038/nri3045 · Cited by 465
Photoimmunology: how ultraviolet radiation affects the immune system
Bernard, J. J., Gallo, R. L., & Krutmann, J. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0185-9 · Cited by 329
Beneficial effects of UV radiation other than via vitamin D production
Juzeniene, A., & Moan, J. (2012) · Dermato-Endocrinology · doi:10.4161/derm.20013 · Cited by 226
“The observed effects could be mediated independently by photoadaptation (development of solar elastosis) and by higher vitamin D levels.(47,50,52)”
BackgroundNoncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models
Skobowiat, C., Oak, A. S. W., Kim, T.-K., Yang, C. H., Pfeffer, L. M., Tuckey, R. C., & Slominski, A. T. (2017) · Oncotarget · doi:10.18632/oncotarget.14193 · Cited by 44
Ogbah, Z., Visa, L., Badenas, C., Ríos, J., Puig-Butille, J. A., Bonifaci, N., Guino, E., Augé, J. M., Kolm, I., Carrera, C., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-26 · Cited by 28
“The association between 25-hydroxyvitamin D3 levels and/or inherited variation in VDR and melanoma risk has been studied in few populations, mostly from northern countries such as England, USA, Poland and Germany [4,6,21-23].”
Background
Metadata
- Authors
- Field, S., & Newton-Bishop, J. A.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2011-02-03
- Volume
- 5
- Issue
- 2
- Pages
- 197-214
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W1990250712
- Cited by
- 71
- References
- 11
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.